Emerging Biomarkers in Heart Failure | Zendy

Roland R.J. van Kimmenade | Zendy; James L. Januzzi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Emerging Biomarkers in Heart Failure

Author(s) -

Roland R.J. van Kimmenade,

James L. Januzzi

Publication year - 2011

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2011.165720

Subject(s) - heart failure , medicine , biomarker , neurohormones , myocardial infarction , disease , risk stratification , biomarker discovery , bioinformatics , intensive care medicine , proteomics , biology , biochemistry , hormone , gene

Until recently, biomarker testing in heart failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of patients suspected to suffer from this condition. This approach to the use of biomarker testing contrasts with other cardiovascular diagnoses such as acute myocardial infarction, for which biomarkers are integral to disease process definition, risk stratification, and in some cases treatment decision making.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research